Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(19 sites)

Portugal

Site 111003, Funchal

Ukraine

Site 117015, Chernivtsi

Site 117005, Ivano-Frankivsk

Site 117002, Kyiv

Site 117006, Kyiv

Site 117007, Kyiv

Site 117012, Kyiv

Site 117013, Kyiv

Site 117014, Kyiv

Site 117016, Kyiv

Site 117017, Kyiv

Site 117018, Kyiv

Site 117020, Kyiv

Site 117021, Kyiv

Site 117022, Lutsk

Site 117003, Ternopil

Site 117004, Uzhhorod

Site 117010, Uzhhorod

Site 117019, Uzhhorod